Key facts
- MIZUHO FINANCIAL GROUP INC filed SCHEDULE 13G/A for Lexeo Therapeutics, Inc. Common Shares (LXEO).
- Disclosed ownership: 6.6%.
- Date of event: 31 Mar 2025.
MIZUHO FINANCIAL GROUP INC - 31 Mar 2025 SCHEDULE 13G/A Report for Lexeo Therapeutics, Inc. Common Shares (LXEO)
- Filing manager
- MIZUHO FINANCIAL GROUP INC
- Reporting owner
- Mizuho Financial Group, Inc.
- Disclosed shares
- 2,203,631 shares
- Ownership percentage
- 6.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 May 2025, 06:55:31 UTC
- Event date
- 31 Mar 2025
- Previous filing
- 13 Feb 2025
- SEC filing
- View on sec.gov
Reporting parties
Subject security
Ownership signal
SEC evidence
Key filing fact
MIZUHO FINANCIAL GROUP INC disclosed 6.6% ownership in Lexeo Therapeutics, Inc. Common Shares (LXEO) on 31 Mar 2025.
Change
- Previous schedule filing date: 13 Feb 2025.
- Current filing was accepted on 13 May 2025, 06:55.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Mizuho Financial Group, Inc. | 6.6% | 2,203,631 | 2,203,631 | 0 | /s/ Takahiro Katsura | Takahiro Katsura, Managing Director, Global Corporate Function Coordination Department |
CIK / CUSIP context first